Mathews Journal of Cancer Science

2474-6797

Previous Issues Volume 1, Issue 1 - 2016

Research Article Full-Text  PDF  

Distinguish Between Benign and Malignant Prostate Using the Trace Element Content Ratios in Prostatic Tissue as Tumor Markers

Vladimir Zaichick1,Sofia Zaichick2

Department of Radionuclide Diagnostics, Medical Radiological Research Centre, Russia.

2Department of Medicine, University of Illinois College of Medicine, USA.

Corresponding Author:Vladimir Zaichick, Department of Radionuclide Diagnostics, Medical Radiological Research Centre, Koroleva Str- 4, Obninsk 249036, Kaluga Region, Russia, Tel: +7 (48439) 60289; E-Mail: [email protected]

Received Date: 28 Jul 2016   
Accepted Date: 18 Aug 2016   
Published Date: 24 Aug 2016

Copyright © 2016 Zaichick V

Citation:Zaichick V and Zaichick S. (2016). Distinguish Between Benign and Malignant Prostate Using the Trace Element Content Ratios in Prostatic Tissue as Tumor Markers. Mathews J Cancer Sci. 1(1): 006.

 

ABSTRACT

The aim of the study was the development of new highly precise testing methods for early diagnosis of prostate cancer. For this purpose the values of the zinc/silver (Zn/Ag), zinc/cobalt (Zn/Co), zinc/chromium (Zn/Cr), zinc/iron (Zn/Fe), zinc/ mercury (Zn/Hg), zinc/rubidium (Zn/Rb), zinc/antimony (Zn/Sb), zinc/scandium (Zn/Sc), and zinc/selenium (Zn/Se) mass fraction ratios in normal (n = 37), benign hypertrophic (n = 43) and cancerous tissues (n = 60) of the human prostate gland were calculated using data obtained by instrumental neutron activation analysis. Mean values ± standard error of mean (M ± SΕΜ) for trace element mass fraction ratios in normal tissue were: Zn/Ag – 32270 ± 5360, Zn/Co – 27010 ± 3720, Zn/Cr – 2650 ± 360, Zn/Fe – 10.9 ± 1.4, Zn/Hg – 27010 ± 3720, Zn/Rb – 73.6 ± 6.6, Zn/Sb – 34330 ± 6160, Zn/Sc – 46790 ± 7870, and Zn/Se – 1550 ± 170, respectively. It was observed that in benign hypertrophic tissues the Zn/Cr, Zn/ Hg, Zn/Sb, and Zn/Se mass fraction ratios were lower than in normal tissues. In cancerous tissue all investigated mass fraction ratios were significantly (p < 0.001) lower than in normal and benign hypertrophic tissues of the prostate. Finally, we propose to use the estimation of Zn/Ag, Zn/Cr, Zn/Fe, Zn/Hg, and Zn/Sb mass fraction ratios in a needle-biopsy core as an accurate tool to diagnose prostate cancer. Sensitivity, specificity, and accuracy of these tests were in ranges 96-100%, 89-100%, and 94-100%, respectively. Application of the Zn/trace element mass fraction ratios instead the Zn mass fraction is more suitable for PCa diagnosis, because accuracy of Zn/trace element mass fraction ratios does not depend on sample mass and changes in moisture content.

KEYWORDS

Trace Element; Trace Element Mass Fraction Ratios; Prostate; Benign Prostatic Hypertrophy; Prostatic Carcinoma; Neutron Activation Analysis.


Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com